Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05749445

Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients

Conditions: Hospitalized Patients

Sex: All
Enrollment: 200
Sponsor: First People's Hospital of Hangzhou

Location: China

Summary

The primary objective of the study was to assess the appropriateness of antiviral therapy with nirmatrelvir-ritonavir in hospitalized patients.

Eligibility Criteria

Inclusion Criteria:hospitalized patients receiving at least one dose nirmatrelvir-ritonavirExclusion Criteria:None

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05749445). StuddyBuddy aggregates publicly available trial information.